Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma-Reference-Cited by-同舟云学术

Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma

Published:2024-03 Issue:3 Volume:8 Page:
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:HemaSphere

Author:

Mellgard George¹,Gilligan Molly¹,Cliff Edward R. Scheffer²,Bhutani Divaya³,Mohyuddin Ghulam R.⁴,Eisenberger Andrew³,Lentzsch Suzanne³,Chakraborty Rajshekhar³^ORCID

Affiliation:

1. Department of Medicine Columbia University Irving Medical Center New York New York USA

2. Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA

3. Columbia University Herbert Irving Comprehensive Cancer Center New York New York USA

4. University of Utah Salt Lake City Utah USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hem3.61

Reference15 articles.

1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

2. Prevalence of smoldering multiple myeloma based on nationwide screening

3. Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

4. Survival in smouldering myeloma and symptomatic myeloma: Is there an emerging Will Rogers phenomenon?

5. Changing Patterns of Symptomatic Myeloma after the Implementation of the 2014 IMWG Diagnostic Criteria and Reduced Early Mortality

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating early intervention in smoldering myeloma clinical trials: a systematic review;The Oncologist;2024-09-05

2. How to Identify and Manage High-Risk Smoldering Multiple Myeloma;Current Oncology Reports;2024-08-23